Join us in our discussion on survival analysis method with focus on the application of two Bayesian methods for time to event data at 4pm (BST) on Thursday 11 July.
Our two presenters are Peter Thall from MD Anderson and Kyu Ha Lee from Harvard. The discussants are: Axel Gandy, Imperial College London (RSS discussant) and Neby Bekele, Gilead Sciences (PSI discussant).
The webinar is sponsored by Wiley who will make both papers free to access for a few weeks before and after the webinar.
In preparation and prior to the day of the webinar, please follow the link above to obtain your personal dial in details and register with the webinar software. After registering via this link, you will receive a confirmation email containing information about joining the webinar, including details on how to dial-in via the telephone. Please allow enough time before joining to download the correct software.
Audio recordings will be available shortly after the JC to download from the PSI website. The meetings are open to everyone regardless to whether you are a member of PSI or RSS.
For further info/feedback, or to submit a question to the authors in advance of the meeting please contact email@example.com
PSI Webinar - Main statistical approaches for quantitative decision-making in drug development
We performed a survey among pharmaceutical companies, targeting people with different profiles (statisticians, non-statisticians and decision-makers) working at different stages of the clinical development (study level, development level or portfolio level).
A PSI ToxSIG webinar - Big Data, Data Science, AI and other buzzwords: What does the Data-Driven Hype mean for Pharmaceutical Analytics?
The last 15 years has seen a massive shift in the role of data and analytics, driven by the increased hype around big data, data science, machine learning and AI. This presents both challenges and opportunities for analytic teams. This webinar will strip back the hype to look at what these buzzwords really mean, and talk about the impact this is having on the role, remit and operating model of analytic teams in the life sciences industry.
An opportunity to meet statisticians from across the pharmaceutical industry in a relaxed and informal setting. An exciting program of events and a chance to work in small groups on a data analysis challenge. Lunch provided.
A PSI Training Course - Practical Approaches to Designing Adaptive Clinical Trials
This hands-on course will provide a deep dive into 4 software packages used to design adaptive clinical trials.
The course will start by providing a general overview of adaptive designs, explaining the different type of adaptations possible and the benefits of each design. Following this, participants will be given the opportunity to have a go at designing trials in R (using RPACTS), EAST, FACTS, and nQuery.
PSI Training Course - Bayesian Practical Course using R and SAS
This practical training course will give a deep dive into performing Bayesian analyses in R and SAS. It is aimed at statisticians who need to be able to conduct Bayesian analyses as part of their day to day work. By the end of the course participants will be able to conduct their own analyses.
The ITIT course will take 25 delegates new to the industry on a complete drug development experience from discovery to marketing. They will visit 6 companies from October 2020 to July 2021 to learn about 6 topics from experts in their field. The ITIT course will have 6 sessions in continental Europe and 3 - 4 sessions in the UK. It promises to be a truly memorable course.